Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-09-30 00:00:00 ET · period of report 2022-08-16 · accession 0001209191-22-051669 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-09-30	2022-08-16+	CPIX	Jones James	Dir	P - Purchase	$2.44	+976	24.1K	+4%	+$2,377

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-08-30	P	A	34	$2.38	23,611	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2	Common	Common Stock	2022-09-26	P	A	31	$2.49	24,200	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3	Common	Common Stock	2022-09-23	P	A	31	$2.55	24,169	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4	Common	Common Stock	2022-08-16	P	A	32	$2.35	23,287	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5	Common	Common Stock	2022-08-17	P	A	32	$2.31	23,319	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6	Common	Common Stock	2022-08-18	P	A	32	$2.23	23,351	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7	Common	Common Stock	2022-08-19	P	A	32	$2.35	23,383	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8	Common	Common Stock	2022-08-22	P	A	32	$2.51	23,415	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9	Common	Common Stock	2022-08-23	P	A	32	$2.59	23,447	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10	Common	Common Stock	2022-08-24	P	A	32	$2.59	23,479	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11	Common	Common Stock	2022-08-25	P	A	32	$2.62	23,511	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12	Common	Common Stock	2022-08-26	P	A	32	$2.55	23,543	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13	Common	Common Stock	2022-08-29	P	A	34	$2.44	23,577	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14	Common	Common Stock	2022-09-27	P	A	31	$2.57	24,231	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15	Common	Common Stock	2022-08-31	P	A	34	$2.36	23,645	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16	Common	Common Stock	2022-09-01	P	A	34	$2.39	23,679	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17	Common	Common Stock	2022-09-02	P	A	34	$2.42	23,713	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18	Common	Common Stock	2022-09-06	P	A	34	$2.15	23,747	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19	Common	Common Stock	2022-09-07	P	A	34	$2.24	23,781	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20	Common	Common Stock	2022-09-08	P	A	34	$2.22	23,815	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21	Common	Common Stock	2022-09-09	P	A	29	$2.21	23,844	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
22	Common	Common Stock	2022-09-12	P	A	34	$2.46	23,878	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
23	Common	Common Stock	2022-09-13	P	A	34	$2.45	23,912	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
24	Common	Common Stock	2022-09-14	P	A	34	$2.51	23,946	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
25	Common	Common Stock	2022-09-15	P	A	34	$2.47	23,980	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
26	Common	Common Stock	2022-09-16	P	A	34	$2.49	24,014	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
27	Common	Common Stock	2022-09-19	P	A	31	$2.56	24,045	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
28	Common	Common Stock	2022-09-20	P	A	31	$2.54	24,076	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
29	Common	Common Stock	2022-09-21	P	A	31	$2.59	24,107	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
30	Common	Common Stock	2022-09-22	P	A	31	$2.51	24,138	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.